Retrospective feasibility study of Mycobacterium tuberculosis modified lipoprotein as a potential biomarker for TB detection in children

Xinxin Yang, Matthew F. Wipperman, Sharon Nachman, Nicole S. Sampson
doi: https://doi.org/10.1101/2021.03.26.21254411

Article usage

Article usage: April 2021 to July 2025

AbstractFullPdf
Apr 2021406156
May 2021158210
Jun 202171211
Jul 20216349
Aug 202179117
Sep 2021391718
Oct 202139415
Nov 202148930
Dec 20213616
Jan 20222171
Feb 20222436
Mar 20222135
Apr 202220210
May 202224011
Jun 2022212132
Jul 2022240147
Aug 20222427
Sep 202224310
Oct 20222608
Nov 202218210
Dec 202215315
Jan 20231516
Feb 20232337
Mar 202310213
Apr 20232112
May 2023814
Jun 2023745
Jul 2023520
Aug 202314115
Sep 2023743
Oct 2023502
Nov 2023191218
Dec 20231212
Jan 2024401
Feb 20241392
Mar 2024911
Apr 2024633
May 2024726
Jun 20242065
Jul 2024855
Aug 20241224
Sep 20242033
Oct 2024573
Nov 2024516
Dec 2024807
Jan 20259510
Feb 20257386
Mar 2025275811
Apr 202511318
May 202518109
Jun 2025361918
Jul 202515188
Back to top
Posted April 26, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Retrospective feasibility study of Mycobacterium tuberculosis modified lipoprotein as a potential biomarker for TB detection in children
Xinxin Yang, Matthew F. Wipperman, Sharon Nachman, Nicole S. Sampson
medRxiv 2021.03.26.21254411; doi: https://doi.org/10.1101/2021.03.26.21254411
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area